Health and Healthcare Systems

COVID-19: What you need to know about the coronavirus pandemic on 7 April

A visitor wears a mask as she takes pictures at some of 50 acres of Ranunculus flowers at "The Flower Fields" in Carlsbad, California, U.S., March 31, 2021. Picture taken March 31, 2021.    REUTERS/Mike Blake     TPX IMAGES OF THE DAY - RC2UPM96SY89

Masks have become part of everyday life for many. Image: REUTERS/Mike Blake

Joe Myers
Writer, Forum Agenda

Listen to the article

  • This daily round-up brings you a selection of the latest news and updates on the COVID-19 coronavirus pandemic, as well as tips and tools to help you stay informed and protected.
  • Top stories: record daily increase in COVID-19 cases in India; WHO says it's a 'travesty' that some nations unable to start COVID-19 vaccinations; a third of COVID survivors suffer neurological or mental disorders, study finds.
Have you read?

1. How COVID-19 is affecting the globe

Confirmed cases of COVID-19 have passed 132.4 million globally, according to the Johns Hopkins Coronavirus Resource Center. The number of confirmed deaths stands at more than 2.87 million. More than 677.93 million vaccination doses have been administered globally, according to Our World in Data.

India has reported a record 115,736 new COVID-19 cases, according to data from the health ministry.

The number of people being treated for COVID-19 in French intensive care units has hit its highest point in almost a year.

U.S. President Joe Biden said yesterday that all American adults will be eligible for a COVID-19 vaccine by 19 April.

South Korea has reported 668 new COVID-19 cases, its highest daily count since 8 January.

Mexico's health regulator has authorized the emergency use of India's COVID-19 vaccine COVAXIN, Mexican Foreign Minister Marcelo Ebrard said on Tuesday.

The Czech government has authorized a slight relaxing of coronavirus restrictions, with some schools and selected shops set to reopen next week.

California plans to fully reopen its economy on 15 June if COVID-19 hospitalizations are low and stable and vaccine supplies allow, Governor Gavin Newsom said yesterday.

The Japanese metropolis of Osaka is to declare a medical emergency as new COVID-19 infections climb to all-time highs, the Kyodo news agency reported.

COVID-19 fatalities in Brazil passed 4,000 for the first time yesterday.

Toronto is cancelling all in-person schooling as of today, as Canada deals with a variant-driven third wave of the coronavirus pandemic.

Cumulative COVID-19 vaccination doses administered per 100 people in selected countries
The WHO has warned about the slow rollout in many countries. Image: Our World in Data

2. 'Travesty' that some nations unable to start COVID-19 vaccinations: WHO

It's a 'travesty' that some countries are still unable to begin vaccinating health workers and the most vulnerable against COVID-19, the Director-General of the World Health Organization said yesterday.

“Scaling up production and equitable distribution remains the major barrier to ending the acute stage of the COVID-19 pandemic,” Dr Tedros Adhanom Ghebreyesus told a news conference.

“It’s a travesty that in some countries health workers and those at-risk groups remain completely unvaccinated.”

The WHO has also said it expects there to be no reason to change its assessment that the benefits of the Oxford/AstraZeneca vaccine outweigh any risks.

“What we can say is that the appraisal that we have for the moment - and this is under consideration by the experts - is that the benefits-risk assessment for the vaccine is still largely positive,” Rogerio Gaspar, WHO director of regulation and prequalification, told a Geneva news conference.

Loading...

3. A third of COVID survivors suffer neurological or mental disorders: study

One-in-three COVID-19 survivors in a study of more than 230,000 mostly American patients were diagnosed with a brain or psychiatric disorder within six months, scientists said yesterday.

The study, published in the Lancet Psychiatry journal, looked at the health records of 236,379 COVID-19 patients - mostly in the United States - and found that 34% received a diagnosis within six months.

The disorders were significantly more common in COVID-19 patients than in comparison groups of people who recovered from flu or other respiratory infections over the same time period, the scientists said, suggesting COVID-19 had a specific impact.

“Although the individual risks for most disorders are small, the effect across the whole population may be substantial,” said Paul Harrison, an Oxford psychiatry professor who co-led the work.

Discover

What is the Global Alliance for Social Entrepreneurship?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

COVID-19

Share:
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

COPD kills more than lung and breast cancer combined. It's time to change that

Nitin Kapoor

November 22, 2024

A historic leap in cancer vaccines – here’s what you need to know

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum